Testing effectiveness (Phase 2)UnknownNCT05659368What this trial is testingTirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1Who this might be right forWolfram Syndrome Ospedale San Raffaele 10
Not applicableActive Not RecruitingNCT02596191What this trial is testingTools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and BiomarkersWho this might be right forCharcot-Marie-Tooth Disease Type 1A Assistance Publique Hopitaux De Marseille 80
Early research (Phase 1)Study completedNCT00870974What this trial is testingA PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric ConditionsWho this might be right forParkinson DiseaseHuntington DiseaseAutistic Spectrum Disorders+3 more Institute for Neurodegenerative Disorders 48
Large-scale testing (Phase 3)Study completedNCT03860935What this trial is testingEfficacy and Safety of AG10 in Subjects With Transthyretin Amyloid CardiomyopathyWho this might be right forAmyloidosisAmyloid CardiomyopathyTransthyretin Amyloidosis+2 more Eidos Therapeutics, a BridgeBio company 632
Early research (Phase 1)Study completedNCT01427517What this trial is testingIntravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's DiseaseWho this might be right forParkinson's DiseaseGaucher's Disease University of Minnesota 9
Not applicableStudy completedNCT06388291What this trial is testingDeep Brain Stimulation in Tourette SyndromeWho this might be right forTourette SyndromeDeep Brain Stimulation University College, London 18
Not applicableStudy completedNCT01203085What this trial is testingDevelopment of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMTWho this might be right forCharcot Marie Tooth Disease University of Iowa 500
Testing effectiveness (Phase 2)Study completedNCT04435665What this trial is testingNFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)Who this might be right forNeurofibromatosis 1Cutaneous Neurofibroma NFlection Therapeutics, Inc. 48
Testing effectiveness (Phase 2)Ended earlyNCT03980938What this trial is testingWithin Subject Crossover Study of Cognitive Effects of Neflamapimod in Early-Stage Huntington DiseaseWho this might be right forHuntington Disease EIP Pharma Inc 15
Not applicableEnded earlyNCT05683678What this trial is testingUS Selumetinib RegistryWho this might be right forNeurofibromatosis Type 1Plexiform Neurofibromas Alexion Pharmaceuticals, Inc. 37
Testing effectiveness (Phase 2)Study completedNCT00231985What this trial is testingEffectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic DisorderWho this might be right forTourette SyndromeTic Disorders Massachusetts General Hospital 122
Not applicableUnknownNCT04061213What this trial is testingATTR Amyloidosis in Elderly Patients With Aortic StenosisWho this might be right forAortic Stenosis SymptomaticAmyloidosis Cardiac Insel Gruppe AG, University Hospital Bern 489
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06835179What this trial is testingSBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.Who this might be right forUnresectable Metastatic Colorectal CancerMicrosatellite Stable (MSS) Colorectal Cancer (CRC)RAS-mutant Colorectal Cancer The First Affiliated Hospital with Nanjing Medical University 28
Testing effectiveness (Phase 2)Study completedNCT05054725What this trial is testingCombination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard TherapiesWho this might be right forNon-Small Cell Lung Cancer Revolution Medicines, Inc. 47
Not applicableUnknownNCT01218152What this trial is testingMicroarray CGH Analysis of Circulating Tumoral Plasma DNA in NF1 Patients With MPNSTsWho this might be right forNeurofibromatosis Type 1 KU Leuven 20
Large-scale testing (Phase 3)Study completedNCT00206323What this trial is testingA Randomized, Placebo-controlled, Tourette Syndrome Study.Who this might be right forTourette Syndrome Baylor College of Medicine 29
Not applicableStudy completedNCT04007913What this trial is testingIncorporating teleCBIT Into a Hospital-Based Tic ProgramWho this might be right forTic DisordersTourette Syndrome San Jose State University 31
Large-scale testing (Phase 3)Study completedNCT00830063What this trial is testingTanezumab In Osteoarthritis Of The Knee (2)Who this might be right forArthritisOsteoarthritis Pfizer 832
Not applicableLooking for participantsNCT06203106What this trial is testingNYSCF Scientific Discovery BiobankWho this might be right forALSAmyotrophic Lateral SclerosisAlzheimer Disease+26 more New York Stem Cell Foundation Research Institute 10,000
Testing effectiveness (Phase 2)Study completedNCT02247206What this trial is testingVoIP Delivered Behavior Therapy for Tourette SyndromeWho this might be right forTourette SyndromeChronic Tic Disorder University of Wisconsin, Milwaukee 20